Genscript Biotech Corporation (1548.HK)
HKD 9.95
(0.2%)
HKD 9.95
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 839.52 Million | 625.69 Million | 490.09 Million | 390.84 Million | 273.35 Million | 231.01 Million |
| Cost of Revenue | 429.97 Million | 321.61 Million | 207.57 Million | 134.95 Million | 93.06 Million | 72.47 Million |
| Gross Profit | 409.55 Million | 304.08 Million | 282.51 Million | 255.89 Million | 180.29 Million | 158.53 Million |
| Operating Expenses | 409.55 Million | 735.72 Million | 804.05 Million | 544.38 Million | 301.54 Million | 145.79 Million |
| Selling, General and Administrative Expenses | 387.73 Million | 352.1 Million | 303.4 Million | 197.03 Million | 125.61 Million | 79.35 Million |
| Research and Development Expenses | 432.82 Million | 390.09 Million | 358.4 Million | 263.4 Million | 186.02 Million | 74.07 Million |
| Other Expenses | - | -21.47 Million | -12.16 Million | -94.31 Million | -384 Thousand | -36 Thousand |
| Cost and Expenses | 1.25 Billion | 1.05 Billion | 1.01 Billion | 679.33 Million | 394.61 Million | 218.26 Million |
| Operating Income | -415.79 Million | -438.11 Million | -379.28 Million | -204.54 Million | -131.34 Million | 5.11 Million |
| Interest Expense | 27.51 Million | 13.26 Million | 2.37 Million | 1.41 Million | 781 Thousand | 52 Thousand |
| Income Tax Expense | 4.14 Million | 3.71 Million | 964 Thousand | 477 Thousand | 3.82 Million | 1.94 Million |
| Earnings before Tax | -350.97 Million | -431.69 Million | -517.36 Million | -281.9 Million | -113.69 Million | 22.7 Million |
| Net Income | -95.47 Million | -226.85 Million | -358.71 Million | -204.94 Million | -96.91 Million | 21.21 Million |
| Earnings Per Share Basic | -0.05 | -0.11 | -0.18 | -0.11 | -0.05 | 0.01 |
| Earnings Per Share Diluted | -0.05 | -0.11 | -0.18 | -0.11 | -0.05 | 0.01 |
| Weighted Average Shares Outstanding | 2.1 Billion | 2.09 Billion | 2.03 Billion | 1.9 Billion | 1.85 Billion | 1.79 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.1 Billion | 2.09 Billion | 2.03 Billion | 1.9 Billion | 1.85 Billion | 1.83 Billion |
| Gross Margin | 0.49 | 0.49 | 0.58 | 0.65 | 0.66 | 0.69 |
| EBIT Margin | -0.30 | -0.62 | -0.70 | -0.45 | -0.41 | 0.08 |
| Profit Margin | -0.11 | -0.36 | -0.73 | -0.52 | -0.35 | 0.09 |
| EBITDA | -249.42 Million | -389.03 Million | -341.56 Million | -174.7 Million | -112.36 Million | 17.44 Million |
| Earnings Before Tax Margin | -0.50 | -0.70 | -0.77 | -0.52 | -0.48 | 0.02 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 561.37 Million | 839.52 Million | 448.21 Million | 391.31 Million | 625.69 Million | 316.1 Million |
| Cost of Revenue | 254.38 Million | 429.97 Million | 213.71 Million | 216.26 Million | 321.61 Million | 180.52 Million |
| Gross Profit | 306.98 Million | 409.55 Million | 234.5 Million | 175.04 Million | 304.08 Million | 135.58 Million |
| Operating Expenses | 457.75 Million | 808.62 Million | 427.72 Million | 433.15 Million | 735.72 Million | 336.38 Million |
| Selling, General and Administrative Expenses | 221.37 Million | - | 202.23 Million | 190.28 Million | - | 183.83 Million |
| Research and Development Expenses | 236.38 Million | - | 225.49 Million | 207.33 Million | - | 212.49 Million |
| Other Expenses | - | -27.03 Million | - | - | -21.47 Million | - |
| Cost and Expenses | 712.14 Million | 1.23 Billion | 641.44 Million | 649.41 Million | 1.05 Billion | 516.9 Million |
| Operating Income | -150.77 Million | -415.79 Million | -193.22 Million | -222.56 Million | -438.11 Million | -260.74 Million |
| Interest Expense | - | 27.51 Million | - | - | 13.26 Million | - |
| Income Tax Expense | 10.04 Million | 4.14 Million | 3.03 Million | 1.1 Million | 3.71 Million | 7.53 Million |
| Earnings before Tax | -205.58 Million | -350.97 Million | -106.32 Million | -244.65 Million | -431.69 Million | -201.91 Million |
| Net Income | -175.11 Million | -95.47 Million | -1.89 Million | -93.58 Million | -226.85 Million | -91.34 Million |
| Earnings Per Share Basic | -0.08 | - | -0.00 | -0.04 | - | -0.04 |
| Earnings Per Share Diluted | -0.08 | - | -0.00 | -0.04 | - | -0.04 |
| Weighted Average Shares Outstanding | 2.11 Billion | 2.1 Billion | 1.99 Billion | 2.1 Billion | 2.09 Billion | 2.1 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.11 Billion | 2.1 Billion | 2.11 Billion | 2.1 Billion | 2.09 Billion | 2.1 Billion |
| Gross Margin | 0.55 | 0.49 | 0.52 | 0.45 | 0.49 | 0.43 |
| EBIT Margin | -0.21 | - | -0.37 | -0.50 | - | -0.75 |
| Profit Margin | -0.31 | -0.11 | -0.00 | -0.24 | -0.36 | -0.29 |
| EBITDA | -117.93 Million | - | -164.28 Million | -194.23 Million | - | -236.13 Million |
| Earnings Before Tax Margin | -0.27 | -0.50 | -0.43 | -0.57 | -0.70 | -0.82 |
007340
0P2J
GLWLF
NAU
ALI
MODIS